Leroux-250 Injection



Cefuroxime Axetil 250mg eq. to Anhydrous

• A second generation cephalosporin, highly resistant to destruction by Beta-lactamases produced by Staphylococci & most of gram- negative bacteria.
• First line treatment option due to its excellent efficacy, safety & tolerability profile.
• Rapidly penetrates into body tissues and fluids.
• Shows extended half life which allows longer dosing interval and reduction in total drug cost.
• Effectively reduces incidence of post operative infections in patients undergoing surgical procedure.
• A very safe drug without causing nephrotoxicity in comparison to other cephalosporins. • Produces more rapid bacterial response & well tolerated as compared with cephalothin.
• Provides good efficacy and better safety profile in treatment of acute bronchitis as compared to amoxicillin - clavulanic acid.
• Superior in both terms of clinical efficacy and global utility.

Indication :
• Acute & chronic bronchitis
• Otitis media
• Pharyngitis
• Bone & ioint infections
• Septicemia
• Meningitis
• Soft Tissue infectons
• Tonsillities
Ensures victory in the war against resistance

More Information
Is Prescribed Yes
Composition Cefuroxime Axetil 250mg eq. to Anhydrous
Write Your Own Review
You're reviewing:Leroux-250 Injection
Your Rating
Back to Top